Brief: Galectin Therapeutics Reports Financial Results For The Quarter Ended March 31

Galectin Therapeutics

16/05/2022 13:14

May 16 (Reuters) - Galectin Therapeutics Inc  GALT.O :
    * GALECTIN THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE
QUARTER
ENDED MARCH 31, 2022 AND PROVIDES BUSINESS UPDATE
    * QUARTERLY LOSS PER SHARE $0.17
    * AS OF MARCH 31, 2022, COMPANY HAD $31.6 MILLION OF CASH
AND CASH
EQUIVALENTS
    * GALECTIN THERAPEUTICS - HAS SUFFICIENT CASH TO FUND
CURRENTLY
PLANNED OPERATIONS, RESEARCH AND DEVELOPMENT ACTIVITIES THROUGH
AT LEAST MAY 16, 2023

Source text for Eikon:  ID:nGNX9pQV2v 
Further company coverage:  GALT.O 

 ((Reuters.Briefs@thomsonreuters.com;))